With two fully commercialised technologies proven at utility scale, complemented by an active New Product development pipeline Bluewater Bio’s capabilities now include:
-
HYBACS® (enhanced activated sludge process)
-
FilterClear™ (high throughput multi-media filtration)
-
GHG-Tox® (nitrification & greenhouse gas monitoring)
-
NeoTech™ (highly efficient UV disinfection)
-
CFIC® (next-generation moving bed bioreactor (MBBR) technology)
-
Operational & Maintenance services (supporting a population equivalent of c. 1 million)
-
World Class R&D team, based at Cranfield University, UK
Bluewater Bio’s growing technology portfolio is focused primarily on the rapid upgrading, optimisation and monitoring of water and wastewater treatment plants. The company has a particular emphasis on reducing:
-
Capital, operational and compliance costs
-
Energy & chemical consumption
-
Physical & environmental footprint
-
Greenhouse gas emissions
-
Construction and commissioning times
Bluewater Bio not only develops its own innovations but also scours adjacent markets for complementary IP, licence opportunities and partnerships.